Immunotherapy in Urothelial Carcinoma

PFIZER, S.A

Object

Topic: Oncology.

Destination: The intent of this RFP is to support independent education initiatives for healthcare professionals involved in the treatment of patients with locallyadvanced or metastatic urothelial carcinoma (mUC), including oncologists, urologists, and specialty nurses.

Budget: $250,000.

Duration: Up to 18 months.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: